Views & Analysis Next wave: how pharma analytics can be improved with new tec... Pharmaceutical companies have always had access to a steady stream of data to look at what has happened in the past and to try to predict future prescribing trends.
Views & Analysis How digital is reversing fortunes in R&D A new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma R&D.
Events Partner Content 2019 Indegene Digital Summit - From Blockbuster Drugs to Blo... First-of-its-kind summit for Pharma & Biotech
Partner Content Partner Content Understanding the Medical Continuum Building a full picture of the development of a drug can be a time-consuming process.
Partner Content Partner Content “The important thing is to not stop questioning.” (Albert Ei... Intuition and experience – the ideal combination for finding a solution to an issue… or is it?
Partner Content Partner Content Making medical affairs a strategic advantage Medical Affairs was once seen as a supportive role, but today a good team can be a strategic advantage.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends